2 directorsName after signing inVisible after signing in and 1 other
Documentsfilings and deeds
16-07-202615 days before the deadline
2025abbreviated format
Gross margin from €63,984 to €87,778Result from €29,678 to €45,003Hidden nameVisible after signing in appointed as director02-10Equity from €149,357 to €194,360Investments €41,176Cash from €4,866 to €6,897
The 2019 accounts came in latest, 68 days after the end of the period.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Name after signing inVisible after signing in appointed as director
General meeting of 16-09-2025 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0630764571
Company renamed from BE PHARMA PUURS to BE PHARMA MANAGEMENTName hiddenVisible after signing in changes role from manager to statutory director · “Het aanleggen, het oordeelkundig uitbouwen en beheren van een onroerend vermogen: alle verrichtingen met…” (deed in Dutch) · Legal-form conversion: from private limited company (pre-2019) to private limited company · Gazette deed
Registered office moved from Sint-Amands to Puurs
Capital increase of €100,000 to €118,600 · The capital rose from €18,600 to €118,600 · The registered office moved from Smissen 2A, 2890 Sint-Amands to Guido Gezellelaan 37, 2870 Puurs · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as BE Pharma Management: business and other management consultancy (NACE 70200). They are comparable in size and age: total assets between €459,000 and €574,000, founded between 2014 and 2016.
What is the company number of BE Pharma Management?
The company number of BE Pharma Management is 0630.764.571. The VAT number is the same number with BE in front: BE 0630.764.571.
Where is BE Pharma Management based?
The registered office is at G. Gezellelaan 37, 2870 Puurs-Sint-Amands.Company details
What does BE Pharma Management do?
According to the KBO register, the main activity is business and other management consultancy (NACE 70200).
What is the legal form of BE Pharma Management?
BE Pharma Management is a private limited company (BV).
When was BE Pharma Management founded?
BE Pharma Management was founded on 21-05-2015.
Is BE Pharma Management still active?
Yes, BE Pharma Management is an active enterprise in the KBO register.
What is the turnover of BE Pharma Management?
The turnover in financial year 2025 is ≈ €170,000. This figure is estimated from the gross margin of €87,778 and 47 comparable companies (NACE 70200). It probably lies between €130,000 and €290,000.Financials
Is BE Pharma Management profitable?
In financial year 2025, BE Pharma Management made a profit of €45,003.
Where can I find the annual accounts of BE Pharma Management?
BE Pharma Management filed 10 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of BE Pharma Management due?
BE Pharma Management must file the annual accounts for financial year 2026 by 31-07-2027.Timeline